Home › Hypertrophic Cardiomyopathy › Michigan
Hypertrophic Cardiomyopathy clinical trials in Michigan
3 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in Michigan.
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Spectrum Health Medical Group, Grand Rapids
- Henry Ford Health System, West Bloomfield
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Grand Rapids
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07023614HCMR Re-Imaging Study
- University of Michigan, Ann Arbor
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated Mar 18, 2026 · NCT07054073From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.